Análisis de la acción Hyperliquid Strategies Inc (PURR)

$9.970

+0.122 (+1.22%)Al cierre

Loading chart…

Máximo: 9.985
Apertura: 9.800
Precio medio ponderado por volumen: 9.79
Volumen: 9.50M
Capitalización: —
Mínimo: 9.420
Importe: 93.04M
EV/EBITDA, TTM: 0.37

Hyperliquid Strategies Inc is a digital asset treasury company. The Company is focused on accumulating HYPE, the native token of Hyperliquid, a high-performance blockchain custom-built to house all of finance. The Company’s subsidiary is Sonnet BioTherapeutics Holdings, Inc., which is an oncology-focused biotechnology company with a proprietary platform for innovating biologic drugs of single or bifunctional action.

Análisis de IA of Hyperliquid Strategies Inc (PURR)

Comprar

Hyperliquid Strategies Inc (PURR) is a good buy right now due to its recent stock buyback program expansion to $100 million, which signals strong confidence from the Board in the company's future. Additionally, the stock has shown impressive long-term performance with a 1-year change of +596.83%. However, the current RSI is at 29.95, indicating that the stock is oversold, which could present a buying opportunity. The main risk is the forward P/E ratio of 14.20, which suggests that the stock may be overvalued if future earnings do not meet expectations.

Métricas de valoración

El PER previsto actual de Hyperliquid Strategies Inc (PURR) es 3.22, frente a su media de 5 años de 13.39.

PER previsto

Muy infravalorado

Media 5A P/E

13.39

P/E actual

3.22

Sobrevalorada

16.28

Infravalorada

10.49

EV/EBITDA previsto

Valor razonable

Media 5A EV/EBITDA

0.39

EV/EBITDA actual

0.37

Sobrevalorada

0.47

Infravalorada

0.30

Precio/ventas previsto

Valor razonable

Media 5A P/S

50.91

P/S actual

37.74

Sobrevalorada

70.35

Infravalorada

31.46

Ballenas con PURR en cartera

BIT Capital GmbH

+ Con en carteraPURR

-3.28%

Rentabilidad a 3 meses

Discovery Capital Management, LLC

+ Con en carteraPURR

-3.52%

Rentabilidad a 3 meses

Cronología de eventos

2026-10-23 (ET)